Shoaib Afzal

Shoaib Afzal serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His clinical appointment is based at Herlev and Gentofte Hospital where he functions as Chief Physician in Clinical Biochemistry since 2017. His academic trajectory spans epidemiological research with extensive work on cardiovascular and respiratory diseases using population cohorts and registry data.

His educational background includes:

• DMSc in Medicine (2019): A Population-based Study on Vitamin D, Body Mass Index, Morbidity, and Mortality
• PhD in Medicine (2011): Pharmacogenetics of 5-FU-based adjuvant treatment of colorectal cancer
• MD (2005)

A leading researcher in clinical and genetic epidemiology, Afzal investigates cardiovascular disease mechanisms, vitamin D metabolism, obstructive pulmonary conditions, and obesity-related pathologies. His methodological expertise encompasses causal inference approaches applied to large-scale population studies like the Copenhagen General Population Study. Recent work heavily utilizes metabolomics for disease prediction and explores socioeconomic determinants of health outcomes.

Analysis of his 227 research outputs (including 8 recent 2025 publications) reveals a dominant focus on cardiovascular epidemiology with strong secondary themes in HIV-related comorbidities, lipid metabolism disorders, and aging populations. His work frequently employs registry-based cohort designs with advanced statistical modeling, demonstrating consistent collaboration with B.G. Nordestgaard's research group. Key publication venues include European Heart Journal, The Lancet Regional Health - Europe, and specialized cardiology/endocrinology journals.

Teaching responsibilities include ongoing lectures in clinical biochemistry for medical students and post-graduate research training courses since 2020, building on earlier teaching in anatomy (2001) and clinical pharmacology (2009-2010). His clinical career progression from House Job (2005) through residency to Chief Physician reflects deep integration of academic medicine with hospital-based practice.

Research operations leverage the Copenhagen General Population Study infrastructure and nationwide Danish registries, with recent projects examining socioeconomic disparities in semaglutide use, remnant cholesterol pathophysiology, and HIV cardiovascular complications. Current external positions maintain his hospital-based clinical biochemistry leadership while supporting population health research translation.